Scam, kidnap by South African police

Scam, kidnap by South African police

Medical Writing Institute click here

MJoTAtalks click here

Emerald Pademelon Press LLC click here

Peace Scientists click here

Dr Susanna loves the countries and the peoples of Africa

Scam, kidnap by South African police

Scam, kidnap by South African police

Bookmark and Share
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
Diabetes News
Clinical trials testing therapies for diabetes

Latest Top (15) News

Bariatric Embolization of Arteries With Imaging Visible Embolics (BEATLES)
Conditions:   Obesity;   Morbid Obesity;   Weight Loss
Interventions:   Device: Bariatric Embolization of Arteries with imaging visible Embolics;   Other: Control Arm
Sponsors:   Johns Hopkins University;   Biocompatibles UK Ltd
Not yet recruiting

Fri, 13 Dec 2019 12:00:00 EST

Development and Testing of a Mobile Health Application for Management of Gestational Diabetes
Conditions:   Diabetes, Gestational;   Telemedicine
Intervention:   Behavioral: Develop a mobile app that supports self- management and treatment for Nepalese GDM patients
Sponsors:   Rutgers, The State University of New Jersey;   Nepal Health Research Council;   University of Connecticut;   John E. Fogarty International Center (FIC);   Dhulikhel Hospital
Not yet recruiting

Fri, 13 Dec 2019 12:00:00 EST

Ethnic Differences in Iron Absorption (FeGenes)
Conditions:   Anemia, Iron Deficiency;   Iron Overload
Sponsors:   Cornell University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   Office of Dietary Supplements (ODS)

Fri, 13 Dec 2019 12:00:00 EST

Evaluating a Digital Diabetes Education Program
Condition:   Diabetes Mellitus, Type 2
Intervention:   Device: Span Health Mobile Application
Sponsor:   Adam Bataineh
Not yet recruiting

Fri, 13 Dec 2019 12:00:00 EST

Interaction Between Omeprazole and Gliclazide in CYP2C19 Normal/ Ultrarapid Metabolisers
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Omeprazole;   Drug: Placebo oral tablet;   Drug: Gliclazide
Sponsors:   University of Sarajevo;   General Hospital Prim. Dr. Abdulah Nakas;   University of Dundee

Fri, 13 Dec 2019 12:00:00 EST

Pancreatic Islet Transplantation to the Anterior Chamber of the Eye
Conditions:   Type 1 Diabetes;   Visual Impairment
Intervention:   Procedure: Islet implantation
Sponsor:   Imperial College London
Not yet recruiting

Fri, 13 Dec 2019 12:00:00 EST

Short-term Effects of Dapagliflozin on Peak VO2 in HFrEF
Conditions:   Heart Failure With Reduced Ejection Fraction;   Type 2 Diabetes
Interventions:   Diagnostic Test: Maximal functional capacity by cardiopulmonary exercise testing;   Diagnostic Test: Echocardiography;   Behavioral: Evaluation of quality of life health related;   Diagnostic Test: Submáximal functional capacity assesment by 6 minutes walk test
Sponsor:   Fundación para la Investigación del Hospital Clínico de Valencia

Fri, 13 Dec 2019 12:00:00 EST

The Omeza Protocol for Chronic Ulcers
Conditions:   Venous Leg Ulcer;   Diabetic Foot Ulcer
Intervention:   Device: Wound dressing
Sponsor:   Omeza, LLC
Not yet recruiting

Fri, 13 Dec 2019 12:00:00 EST

Advanced Prosthetic Devices for Lower Limb Amputees
Condition:   Prostheses and Implants
Intervention:   Device: prosthetic device
Sponsor:   Nottingham Trent University

Thu, 12 Dec 2019 12:00:00 EST

Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)
Condition:   Type 2 Diabetes
Interventions:   Drug: IDegLira;   Drug: IGlarLixi;   Drug: Insulin/Canaglifozin;   Drug: Insulin/Dapaglifozin;   Drug: Insulin/Empaglifozin;   Drug: Basal Bolus
Sponsor:   University of Campania "Luigi Vanvitelli"

Thu, 12 Dec 2019 12:00:00 EST

Hyperglycemia as a Prognostic Factor In Acute Ischemic Stroke Patients
Condition:   Acute Ischemic Stroke Patients
Intervention:   Other: observational study
Sponsor:   Ain Shams University

Thu, 12 Dec 2019 12:00:00 EST

Methotrexate and Metformin in Rheumatoid Arthritis Patients
Condition:   Arthritis, Rheumatoid
Interventions:   Drug: Metformin treatment;   Other: Placebo;   Drug: Methotrexate treatment
Sponsors:   University Hospital, Bordeaux;   Ministry for Health and Solidarity, France
Not yet recruiting

Thu, 12 Dec 2019 12:00:00 EST

Pivotal Omnipod Horizon™ Automated Glucose Control System
Condition:   Type 1 Diabetes Mellitus
Intervention:   Device: Omnipod Horizon™ Automated Glucose Control System
Sponsor:   Insulet Corporation
Not yet recruiting

Thu, 12 Dec 2019 12:00:00 EST

Surgical Innovation for Diabetes Treatment
Conditions:   Obesity;   Diabetes Mellitus, Type 2
Interventions:   Procedure: Short BPL RYGB;   Procedure: Long BPL RYGB
Sponsors:   Hospital de Sao Sebastiao;   Instituto de Ciências Biomédicas Abel Salazar;   The Novo Nordisk Foundation Center for Basic Metabolic Research

Thu, 12 Dec 2019 12:00:00 EST

vDPP Facilitated With Community Care Coordination
Condition:   Diabetes Prevention
Intervention:   Behavioral: vDPP
Sponsors:   Yale University;   Centers for Disease Control and Prevention
Not yet recruiting

Thu, 12 Dec 2019 12:00:00 EST
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.

Latest Top (10) News

FDA approves use of drug to reduce risk of cardiovascular events in certain adult patient groups
FDA expands the indication of Vascepa (icosapent ethyl) capsules to reduce the risk of cardiovascular events as an adjunct to maximally tolerated statin therapy in high-risk adult patients with elevated triglyceride levels. It is a fish oil-derived omega-3 fatty acid product indicated to reduce the

Fri, 13 Dec 2019 16:24:21 EST

FDA clears first fully disposable duodenoscope, eliminating the potential for infections caused by ineffective reprocessing
The FDA today cleared for marketing in the U.S. the first fully disposable duodenoscope. The EXALT Model D Single-Use Duodenoscope is intended to provide visualization and access to the upper gastrointestinal (GI) tract to treat bile duct disorders and other upper GI problems.

Fri, 13 Dec 2019 13:29:52 EST

FDA authorizes first interoperable, automated insulin dosing controller designed to allow more choices for patients looking to customize their individual diabetes management device system
The FDA has authorized marketing of an interoperable automated glycemic controller device that automatically adjusts insulin delivery to a person with diabetes by connecting to an alternate controller-enabled insulin pump (ACE pump) and integrated continuous glucose monitor (iCGM).

Fri, 13 Dec 2019 11:48:01 EST

FDA grants accelerated approval to first targeted treatment for rare Duchenne muscular dystrophy mutation
Today, the FDA approved a new treatment for Vyondys 53 (golodirsen) injection to treat Duchenne muscular dystrophy (DMD) patients

Thu, 12 Dec 2019 17:50:44 EST

Statement on new findings and current status of the romaine lettuce E. coli O157:H7 outbreak investigation
Illnesses subsiding, FDA continues to aggressively investigate source and route of contamination to prevent future outbreaks

Thu, 12 Dec 2019 17:08:08 EST

FDA sends warning to companies for offering unapproved umbilical cord blood products that may put patients at risk
FDA sends warning to companies for offering unapproved umbilical cord blood products that may put patients at risk

Thu, 12 Dec 2019 16:43:05 EST

Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s continued efforts to bring competition to the insulin market to lower prices and expand access
FDA is announcing a public hearing to discuss access to affordable insulin products.

Thu, 12 Dec 2019 13:08:33 EST

FDA authorizes first test to aid in newborn screening for Duchenne Muscular Dystrophy
Today, the U.S. Food and Drug Administration authorized marketing of the first test to aid in newborn screening for Duchenne Muscular Dystrophy (DMD), a rare genetic disorder that causes progressive muscle deterioration and weakness.

Thu, 12 Dec 2019 11:47:07 EST

FDA issues warning letter for not including the most serious risks in advertisement for medication-assisted treatment drug
FDA issues warning letter to Alkermes, Inc., for misbranding the drug Vivitrol (an extended-release injection formulation of naltrexone) by omitting warnings about the most serious risks associated with the drug from promotional materials

Wed, 11 Dec 2019 11:14:31 EST

FDA underscores that consumers should not use drugs, dietary supplements and devices recalled from Basic Reset and Biogenyx following consent decree for federal violations
The U.S. Food and Drug Administration is alerting consumers of a recall of 25 drug, dietary supplement and medical device product lines distributed by Basic Reset and Biogenyx.

Tue, 10 Dec 2019 17:31:03 EST
Diabetes news from the American Diabetes Association

Latest Top (5) News